Central Trust Company’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-3,860
Closed -$821K 1273
2014
Q4
$821K Buy
3,860
+2,920
+311% +$581K 0.07% 225
2014
Q3
$167K Sell
940
-75
-7% -$12.5K 0.01% 452
2014
Q2
$172K Hold
1,015
0.01% 454
2014
Q1
$126K Sell
1,015
-10
-1% -$1.22K 0.01% 502
2013
Q4
$114K Sell
1,025
-35
-3% -$3.34K 0.01% 499
2013
Q3
$96K Sell
1,060
-263
-20% -$23.6K 0.01% 521
2013
Q2
$112K Buy
+1,323
New +$137K 0.01% 468

Other funds holding AGN

Central Trust Company's AGN Position: Q1 2015 in Review

Central Trust Company sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,860 shares — an estimated $821K sold.

Central Trust Company first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $821K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Central Trust Company reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Central Trust Company sold 3,860 Allergan Inc shares in Q1 2015, an estimated $821K.
  • Central Trust Company first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Central Trust Company's Allergan Inc position peaked at $821K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Central Trust Company's 13F filing for Q1 2015, filed 9 Apr 2015.